{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Vasculitis%2C+Central+Nervous+System&page=4", "query": { "condition": "Vasculitis, Central Nervous System", "page": 4 }, "page_size": 10 }, "pagination": { "page": 4, "page_size": 10, "total_count": 73, "total_pages": 8, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Vasculitis%2C+Central+Nervous+System&page=5&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Vasculitis%2C+Central+Nervous+System&page=3&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-21T14:58:31.895Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03166319", "title": "Vessel Wall Imaging for Diagnosis and Monitoring of Central Nervous System (CNS) Vasculitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Vasculitis, CNS", "Vasculitis, Cerebral" ], "interventions": [ { "name": "MRI, including intracranial vessel wall imaging", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 15, "start_date": "2017-07-24", "completion_date": "2020-11-24", "has_results": false, "last_update_posted_date": "2022-03-17", "last_synced_at": "2026-10-21T14:58:31.895Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT03166319" }, { "nct_id": "NCT03410290", "title": "Journey of Patients With Vasculitis From First Symptom to Diagnosis", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Vasculitis", "Systemic Vasculitis", "Behcet's Disease", "CNS Vasculitis", "Cryoglobulinemic Vasculitis", "Eosinophilic Granulomatous Vasculitis", "Temporal Arteritis", "Giant Cell Arteritis", "Granulomatosis With Polyangiitis", "Wegener Granulomatosis", "Henoch Schonlein Purpura", "IgA Vasculitis", "Microscopic Polyangiitis", "Polyarteritis Nodosa", "Takayasu Arteritis", "Urticarial Vasculitis" ], "interventions": [ { "name": "Online Questionnaire", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Pennsylvania", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 456, "start_date": "2018-01-11", "completion_date": "2018-05-21", "has_results": false, "last_update_posted_date": "2018-06-06", "last_synced_at": "2026-10-21T14:58:31.895Z", "location_count": 1, "location_summary": "Tampa, Florida", "locations": [ { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03410290" }, { "nct_id": "NCT02176070", "title": "Reproductive Health in Men and Women With Vasculitis", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Giant Cell Arteritis", "Takayasu's Arteritis", "Polyarteritis Nodosa", "Wegener's Granulomatosis", "Microscopic Polyangiitis", "Churg-Strauss Syndrome", "Behcet's Disease", "Kawasaki Disease", "Henoch-schoenlein Purpura", "Vasculitis, Central Nervous System", "Drug-induced Necrotizing Vasculitis" ], "interventions": [], "intervention_types": [], "sponsor": "University of South Florida", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 467, "start_date": "2011-02", "completion_date": "2012-03", "has_results": false, "last_update_posted_date": "2014-06-26", "last_synced_at": "2026-10-21T14:58:31.895Z", "location_count": 1, "location_summary": "Tampa, Florida", "locations": [ { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02176070" }, { "nct_id": "NCT06130540", "title": "Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Intravenous Secukinumab in Patients With GCA or PMR", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Giant Cell Arteritis", "Polymyalgia Rheumatica" ], "interventions": [ { "name": "Secukinumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "50 Years to 100 Years" }, "enrollment_count": 65, "start_date": "2024-03-27", "completion_date": "2025-04-02", "has_results": false, "last_update_posted_date": "2026-04-01", "last_synced_at": "2026-10-21T14:58:31.895Z", "location_count": 8, "location_summary": "Boca Raton, Florida • Zephyrhills, Florida • Willowbrook, Illinois + 5 more", "locations": [ { "city": "Boca Raton", "state": "Florida" }, { "city": "Zephyrhills", "state": "Florida" }, { "city": "Willowbrook", "state": "Illinois" }, { "city": "Duncansville", "state": "Pennsylvania" }, { "city": "Jackson", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT06130540" }, { "nct_id": "NCT00858884", "title": "Libman-Sacks Endocarditis as a Cause of Neuropsychiatric Systemic Lupus Erythematosus", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Systemic Lupus Erythematosus" ], "interventions": [ { "name": "Clinical and laboratory evaluations, transesophageal echocardiography, carotid duplex, transcranial duplex, and magnetic resonance of the brain", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of New Mexico", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 0, "start_date": "2006-08", "completion_date": "2006-08", "has_results": false, "last_update_posted_date": "2024-01-10", "last_synced_at": "2026-10-21T14:58:31.895Z", "location_count": 1, "location_summary": "Albuquerque, New Mexico", "locations": [ { "city": "Albuquerque", "state": "New Mexico" } ], "official_url": "https://clinicaltrials.gov/study/NCT00858884" }, { "nct_id": "NCT04474847", "title": "Abatacept for the Treatment of Giant Cell Arteritis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Giant Cell Arteritis" ], "interventions": [ { "name": "Abatacept", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Pennsylvania", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 78, "start_date": "2021-03-29", "completion_date": "2029-12", "has_results": false, "last_update_posted_date": "2026-08-20", "last_synced_at": "2026-10-21T14:58:31.895Z", "location_count": 5, "location_summary": "Rochester, Minnesota • New York, New York • Cleveland, Ohio + 2 more", "locations": [ { "city": "Rochester", "state": "Minnesota" }, { "city": "New York", "state": "New York" }, { "city": "Cleveland", "state": "Ohio" }, { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT04474847" }, { "nct_id": "NCT03712345", "title": "Safety and Efficacy Study of IFX-1 in add-on to Standard of Care in GPA and MPA", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Granulomatosis With Polyangiitis (GPA)", "Microscopic Polyangiitis (MPA)" ], "interventions": [ { "name": "IFX-1 low dose", "type": "DRUG" }, { "name": "IFX-1 high dose", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "InflaRx GmbH", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 20, "start_date": "2018-10-15", "completion_date": "2021-05-03", "has_results": true, "last_update_posted_date": "2022-05-26", "last_synced_at": "2026-10-21T14:58:31.895Z", "location_count": 33, "location_summary": "Scottsdale, Arizona • Loma Linda, California • Doral, Florida + 30 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Loma Linda", "state": "California" }, { "city": "Doral", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT03712345" }, { "nct_id": "NCT07138898", "title": "Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Rheumatic Disease" ], "interventions": [ { "name": "Methotrexate", "type": "DRUG" }, { "name": "Sulfasalazine", "type": "DRUG" }, { "name": "Hydroxychloroquine", "type": "DRUG" }, { "name": "Leflunomide", "type": "DRUG" }, { "name": "Azathioprine", "type": "DRUG" }, { "name": "Mycophenolate", "type": "DRUG" }, { "name": "Cyclosporine", "type": "DRUG" }, { "name": "Tacrolimus", "type": "DRUG" }, { "name": "Etanercept", "type": "DRUG" }, { "name": "Adalimumab", "type": "DRUG" }, { "name": "Golimumab", "type": "DRUG" }, { "name": "Certolizumab", "type": "DRUG" }, { "name": "Infliximab", "type": "DRUG" }, { "name": "Rituximab", "type": "BIOLOGICAL" }, { "name": "Belimumab", "type": "BIOLOGICAL" }, { "name": "Tocilizumab", "type": "BIOLOGICAL" }, { "name": "Anakinra", "type": "BIOLOGICAL" }, { "name": "Canakinumab", "type": "BIOLOGICAL" }, { "name": "Abatacept", "type": "BIOLOGICAL" }, { "name": "Secukinumab", "type": "BIOLOGICAL" }, { "name": "Ixekizumab", "type": "BIOLOGICAL" }, { "name": "Bimekizumab", "type": "BIOLOGICAL" }, { "name": "Ustekinumab", "type": "BIOLOGICAL" }, { "name": "Guselkumab", "type": "BIOLOGICAL" }, { "name": "Risankizumab", "type": "BIOLOGICAL" }, { "name": "Tofacitinib", "type": "DRUG" }, { "name": "Upadacitinib", "type": "DRUG" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "NYU Langone Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 80, "start_date": "2025-12-12", "completion_date": "2028-01", "has_results": false, "last_update_posted_date": "2026-07-09", "last_synced_at": "2026-10-21T14:58:31.895Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT07138898" }, { "nct_id": "NCT01241305", "title": "One-Time DNA Study for Vasculitis", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss)", "Giant Cell Arteritis", "Granulomatosis With Polyangiitis (Wegener's)", "Microscopic Polyangiitis", "Polyarteritis Nodosa", "Takayasu's Arteritis" ], "interventions": [], "intervention_types": [], "sponsor": "University of Pennsylvania", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "7 Years", "maximum_age": null, "sex": "ALL", "summary": "7 Years and older" }, "enrollment_count": 1000, "start_date": "2010-10", "completion_date": "2028-08", "has_results": false, "last_update_posted_date": "2026-01-22", "last_synced_at": "2026-10-21T14:58:31.895Z", "location_count": 11, "location_summary": "Los Angeles, California • San Francisco, California • Chicago, Illinois + 8 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Kansas City", "state": "Kansas" }, { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT01241305" }, { "nct_id": "NCT05376319", "title": "PR3-AAV Resilient Remission or PRRR", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Granulomatosis With Polyangiitis", "Microscopic Polyangiitis", "ANCA Associated Vasculitis" ], "interventions": [ { "name": "Obinutuzumab", "type": "DRUG" }, { "name": "Rituximab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 6, "start_date": "2023-06-30", "completion_date": "2024-05-07", "has_results": true, "last_update_posted_date": "2026-05-06", "last_synced_at": "2026-10-21T14:58:31.895Z", "location_count": 3, "location_summary": "Boston, Massachusetts • Rochester, Minnesota • Philadelphia, Pennsylvania", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Rochester", "state": "Minnesota" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT05376319" } ] }